Multimodal Enhancement of Colonic Motility by Acupuncture at ST-36 is Mediated by TRPV1+ Cutaneous Sensory Fibers
Zhang et al. · Frontiers in Bioscience (Landmark Edition) · 2026
Evidence Level
STRONGOBJECTIVE
Investigate whether TRPV1+ fibers at the ST-36 point mediate the effects of acupuncture on colorectal motility
WHO
C57BL/6 mice and TRPV1 transgenic mice
DURATION
1-minute stimulations with immediate analysis
POINTS
ST-36 (Zusanli) - point traditionally used for digestive problems
🔬 Study Design
C57BL/6 (control)
n=6
Traditional acupuncture stimulations
TrpV1Cre
n=2
Analysis of receptor expression
TrpV1ChR2-eYFP
n=8
Optogenetic activation with blue light
TrpV1NpHR-eYFP
n=5
Optogenetic inhibition with yellow light
📊 Results in numbers
Motility improvement with electroacupuncture
Optogenetic activation mimics acupuncture
Inhibition reduces stimulation efficacy
TRPV1+CGRP coexpression
Percentage highlights
📊 Outcome Comparison
Improvement in motility AUC (%)
This study revealed how acupuncture works to improve intestinal problems. Researchers discovered that specific receptors (TRPV1) in the skin at the ST-36 point are responsible for the effects of acupuncture on intestinal motility. This scientifically explains why this point is effective for digestive disorders.
Article summary
Plain-language narrative summary
This experimental study investigated the mechanisms by which acupuncture at the ST-36 (Zusanli) point improves colorectal motility, specifically focusing on the role of TRPV1 (Transient Receptor Potential Vanilloid 1) receptors. The ST-36 point is traditionally used in Chinese medicine to treat gastrointestinal disorders, but the underlying neural mechanisms remained poorly understood. The researchers used an innovative approach combining optogenetic techniques with transgenic animal models to investigate, with temporal and spatial precision, the role of TRPV1+ sensory fibers in mediating the effects of acupuncture. The study used 21 mice divided into different strains: C57BL/6 mice as control, TrpV1Cre mice for molecular characterization, TrpV1ChR2-eYFP for selective optogenetic activation, and TrpV1NpHR-eYFP for optogenetic inhibition.
The methodology included four types of stimulation at the ST-36 point: electroacupuncture (1 mA, 10 Hz), manual acupuncture, thermal stimulation (46°C), and capsaicin application (1%). Colorectal motility was quantified through area under the curve (AUC) and contraction amplitude using an intracolonic balloon system connected to pressure transducers. The results demonstrated that all stimulation modalities significantly increased colorectal motility in C57BL/6 mice. Electroacupuncture showed the most robust effects, with a 376% increase in AUC (p = 0.0174), followed by manual acupuncture (243%, p = 0.0313), thermal stimulation (200%, p = 0.0313), and capsaicin (201%, p = 0.0313).
Immunohistochemical characterization revealed that TRPV1+ neurons in the dorsal root ganglion predominantly coexpress markers of unmyelinated nociceptive fibers: 27% with CGRP (calcitonin gene-related peptide) and 47% with peripherin, but rarely with NF200 (6%) or tyrosine hydroxylase (<1%). This establishes TRPV1 as a specific marker for small- to medium-diameter nociceptive neurons. Selective optogenetic activation of TRPV1+ fibers with blue light (473 nm, 30 mW) in TrpV1ChR2-eYFP mice mimicked the effects of acupuncture, producing significant increases in colorectal motility (p < 0.05). Conversely, optogenetic inhibition with yellow light (593 nm, 30 mW) in TrpV1NpHR-eYFP mice significantly attenuated the effects of all stimulation modalities, reducing efficacy by 65-82% depending on the type of stimulus.
Quantitative analysis showed that TRPV1 contributes differentially to the effects of each modality: electroacupuncture (65% contribution), manual acupuncture (65%), thermal stimulation (78%), and capsaicin (82%). The clinical implications are substantial. The study provides mechanistic evidence that TRPV1+ sensory fibers constitute a convergent neural pathway for multiple modalities of acupuncture stimulation. This suggests that the therapeutic efficacy of acupuncture for functional gastrointestinal disorders can be optimized through targeted modulation of these receptors.
The finding that different stimulation modalities have varying contributions from TRPV1 may inform therapeutic personalization strategies. Limitations include the use of isoflurane anesthesia, which may influence autonomic tone, the limited penetration of transcutaneous optical stimulation, and the absence of direct electrophysiological recordings to quantify the efficiency of optogenetic inhibition. Future studies should employ orthogonal approaches such as selective antagonists and chemogenetic models for additional validation, in addition to investigating complete neural circuits in awake models.
Strengths
- 1Innovative use of optogenetics for temporal and spatial precision
- 2Detailed molecular characterization of TRPV1+ neurons
- 3Multiple stimulation modalities tested
- 4Clear causal evidence through selective activation and inhibition
- 5Rigorous quantification of colorectal motility
Limitations
- 1Small sample size in some experimental groups
- 2Use of anesthesia that may affect autonomic responses
- 3Limited penetration of transcutaneous optical stimulation
- 4Absence of direct electrophysiological recordings
- 5Studies performed only in murine model
Expert Commentary
Prof. Dr. Hong Jin Pai
PhD in Sciences, University of São Paulo
▸ Clinical Relevance
The ST-36 point (Zusanli) holds a prominent position in the treatment of functional gastrointestinal disorders — functional constipation, irritable bowel syndrome with constipation predominance, postoperative dysmotility — and this work offers the mechanistic underpinning that was missing to support more rational therapeutic choices. By demonstrating that TRPV1+ sensory fibers function as a convergent neural pathway for multiple stimulation modalities, the study supports the individualized selection of technique: electroacupuncture and manual acupuncture produced expressive increases in colorectal motility, with 376% and 243% increase in AUC, respectively, which is clinically non-trivial. For the physician treating patients with refractory constipation or with dysmotility associated with chronic opioid use — a population for which pharmacological options are limited — having solid neurobiological data on the mechanism of action at ST-36 strengthens the argument for including acupuncture in the therapeutic plan in a structured and justified manner.
▸ Notable Findings
The most notable finding is the causal demonstration, via optogenetics, that TRPV1+ fibers do not merely participate — they are responsible for 65% to 82% of the prokinetic effect depending on the modality employed. Selective optogenetic activation with blue light was able to reproduce the effects of acupuncture without any needling, and inhibition with yellow light drastically reduced them, establishing causality with a temporal precision that classical pharmacological experiments would hardly achieve. Another piece of data that deserves attention is the immunohistochemical profile: TRPV1+ neurons predominantly coexpress peripherin (47%) and CGRP (27%), confirming their small- to medium-diameter nociceptive identity — which mechanistically connects acupuncture to the peripheral nociceptive system in a much more specific way than previously imagined. The differential contribution of TRPV1 across modalities — greater for capsaicin (82%) and thermal stimulation (78%) than for electroacupuncture (65%) — suggests that different techniques partially recruit distinct neuronal populations, opening space for combined strategies.
▸ From My Experience
In my practice at the Acupuncture Group of the HC-FMUSP Pain Center, ST-36 is one of the most frequently used points in protocols for gastrointestinal dysmotility, and what this work confirms on a molecular basis is something we have observed clinically for decades: the response to this point is relatively early, with patients reporting improvement in intestinal transit within the first three to four sessions. I typically combine electroacupuncture at 2-4 Hz or 10 Hz at ST-36 with auxiliary points such as CV-12, CV-6, and SP-6 in cases of functional constipation, and we routinely schedule cycles of eight to twelve sessions before reassessing. The finding that thermal stimulation and capsaicin also recruit TRPV1+ fibers with comparable efficacy makes me reflect on the use of moxibustion over ST-36 — a technique we have used for years based on classical indication and which now finds support in thermosensitive TRPV1 channels. Elderly patients with chronic constipation and low local pain threshold, in whom I prefer moxibustion to electroacupuncture, seem to respond well — and this study offers a mechanistic explanation for this accumulated empirical observation.
Full original article
Read the full scientific study
Frontiers in Bioscience (Landmark Edition) · 2026
DOI: 10.31083/FBL46975
Access original articleThis study underpins the editorial content of the site.
Condition pages and clinical articles that cite this evidence as the basis of their recommendations.
Scientific Review

Marcus Yu Bin Pai, MD, PhD
CRM-SP: 158074 | RQE: 65523 · 65524 · 655241
PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture. Scientific review and curation of every entry in this library.
Learn more about the author →Medical disclaimer: This content is for educational purposes only and does not replace consultation, diagnosis, or treatment by a qualified professional. Some information may be assisted by artificial intelligence and is subject to inaccuracies. Always consult a physician.
Content reviewed by the medical team at CEIMEC — Integrated Centre for Chinese Medicine Studies, a reference in Medical Acupuncture for over 30 years.
Related articles
Based on this article’s categories